We show that S/R RCC tumors are highly responsive to ICIs, harbor distinctive genomic alterations, a characteristic transcriptional program characterized by the enrichment of MYC-regulated genes that correlates with poor outcomes, and a heavily inflamed microenvironment enriched in features that have been associated with ICI responses. This evidence concerns the gene MYC and renal cell carcinoma.